Literature DB >> 25217162

Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.

Sandip Mukherjee1, Budhaditya Mukherjee1, Rupkatha Mukhopadhyay1, Kshudiram Naskar1, Shyam Sundar2, Jean-Claude Dujardin3, Syamal Roy4.   

Abstract

The efflux of antimony through multidrug resistance protein (MDR)-1 is the key factor in the failure of metalloid treatment in kala-azar patients infected with antimony-resistant Leishmania donovani (Sb(R)LD). Previously we showed that MDR-1 upregulation in Sb(R)LD infection is IL-10-dependent. Imipramine, a drug in use for the treatment of depression and nocturnal enuresis in children, inhibits IL-10 production from Sb(R)LD-infected macrophages (Sb(R)LD-Mϕs) and favors accumulation of surrogates of antimonials. It inhibits IL-10-driven nuclear translocation of c-Fos/c-Jun, critical for enhanced MDR-1 expression. The drug upregulates histone deacetylase 11, which inhibits acetylation of IL-10 promoter, leading to a decrease in IL-10 production from Sb(R)LD-Mϕs. It abrogates Sb(R)LD-mediated p50/c-Rel binding to IL-10 promoter and preferentially recruits p65/RelB to IL-12 p35 and p40 promoters, causing a decrease in IL-10 and overproduction of IL-12 in Sb(R)LD-Mϕs. Histone deacetylase 11 per se does not influence IL-12 promoter activity. Instead, a imipramine-mediated decreased IL-10 level allows optimal IL-12 production in Sb(R)LD-Mϕs. Furthermore, exogenous rIL-12 inhibits intracellular Sb(R)LD replication, which can be mimicked by the presence of Ab to IL-10. This observation indicated that reciprocity exists between IL-10 and IL-12 and that imipramine tips the balance toward an increased IL-12/IL-10 ratio in Sb(R)LD-Mϕs. Oral treatment of infected BALB/c mice with imipramine in combination with sodium stibogluconate cleared organ Sb(R)LD parasites and caused an expansion of the antileishmanial T cell repertoire where sodium stibogluconate alone had no effect. Our study deciphers a detailed molecular mechanism of imipramine-mediated regulation of IL-10/IL-12 reciprocity and its impact on Sb(R)LD clearance from infected hosts.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25217162     DOI: 10.4049/jimmunol.1400710

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Regulatory IgDhi B Cells Suppress T Cell Function via IL-10 and PD-L1 during Progressive Visceral Leishmaniasis.

Authors:  Robert G Schaut; Ian M Lamb; Angela J Toepp; Benjamin Scott; Carolina O Mendes-Aguiar; Jose F V Coutinho; Selma M B Jeronimo; Mary E Wilson; John T Harty; Thomas J Waldschmidt; Christine A Petersen
Journal:  J Immunol       Date:  2016-04-13       Impact factor: 5.422

Review 2.  The enemy within: Targeting host-parasite interaction for antileishmanial drug discovery.

Authors:  Suzanne Lamotte; Gerald F Späth; Najma Rachidi; Eric Prina
Journal:  PLoS Negl Trop Dis       Date:  2017-06-08

3.  Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis.

Authors:  Saptarshi Roy; Devawati Dutta; Eswara M Satyavarapu; Pawan K Yadav; Chhabinath Mandal; Susanta Kar; Chitra Mandal
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

Review 4.  Leishmania-Host Interactions-An Epigenetic Paradigm.

Authors:  Farhat Afrin; Inbesat Khan; Hassan A Hemeg
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

5.  Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis.

Authors:  Maiara Maria Romanelli; Thais Alves da Costa-Silva; Edezio Cunha-Junior; Daiane Dias Ferreira; Juliana M Guerra; Andres Jimenez Galisteo; Erika Gracielle Pinto; Leandro R S Barbosa; Eduardo Caio Torres-Santos; Andre Gustavo Tempone
Journal:  Front Cell Infect Microbiol       Date:  2019-10-29       Impact factor: 5.293

Review 6.  Epigenetic Changes Associated With Interleukin-10.

Authors:  Zhonghua Zheng; Gang Huang; Tong Gao; Tianyi Huang; Mengsha Zou; Yuhao Zou; Shiwei Duan
Journal:  Front Immunol       Date:  2020-06-04       Impact factor: 7.561

Review 7.  Protective or Detrimental? Understanding the Role of Host Immunity in Leishmaniasis.

Authors:  Camila Dos Santos Meira; Lashitew Gedamu
Journal:  Microorganisms       Date:  2019-12-13

8.  The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.

Authors:  Ioannis D Kyriazis; Olga S Koutsoni; Nektarios Aligiannis; Kalliopi Karampetsou; Alexios-Leandros Skaltsounis; Eleni Dotsika
Journal:  Parasit Vectors       Date:  2016-08-09       Impact factor: 3.876

9.  Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances in vitro and in vivo Anti-mycobacterial Activity in Human Macrophages and in Zebrafish.

Authors:  Jôsimar D Moreira; Bjørn E V Koch; Suzanne van Veen; Kimberley V Walburg; Frank Vrieling; Tânia Mara Pinto Dabés Guimarães; Annemarie H Meijer; Herman P Spaink; Tom H M Ottenhoff; Mariëlle C Haks; Matthias T Heemskerk
Journal:  Front Immunol       Date:  2020-02-03       Impact factor: 7.561

10.  Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy.

Authors:  Sandip Mukherjee; Supratim Pradhan; Souradeepa Ghosh; Shyam Sundar; Shantanabha Das; Budhaditya Mukherjee; Syamal Roy
Journal:  Front Cell Infect Microbiol       Date:  2020-11-10       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.